Tumor-Targeted Nanomedicine for Immunotherapy
Horacio Cabral1, Hiroaki Kinoh2, Kazunori Kataoka2,3
1Department of Bioengineering, Graduate School of Engineering, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo 113-8656, Japan.
Accounts of Chemical Research
|November 9, 2020
Summary
Self-assembled nanomedicines offer enhanced cancer immunotherapy by precisely controlling drug delivery to tumors, boosting immune responses, and reducing side effects. These advanced nanomedicines are key to overcoming current limitations in cancer treatment.
Area of Science:
- Oncology
- Immunology
- Nanotechnology
- Materials Science
Background:
- Cancer immunotherapy has revolutionized treatment but suffers from low response rates.
- Nanomedicines offer spatiotemporal control for enhanced immunotherapy and reduced side effects.
- Self-assembled nanomedicines show promise in addressing tumor heterogeneity and malignancy.
Purpose of the Study:
- To review strategies for developing nanomedicines that potentiate antitumor immune responses.
- To discuss the potential of nanomedicines for innovative cell-targeted anticancer treatments.
- To explore challenges and future directions for nanomedicines in immunotherapy.
Main Methods:
- Review of self-assembled nanomedicine strategies for immunotherapy.
- Analysis of nanomedicine mechanisms for enhancing antitumor immunity.
- Discussion of nanomedicine engineering for tumor targeting and immune modulation.
Main Results:
- Nanomedicines can enhance antitumor immunity via immunogenic cell damage, immune microenvironment modulation, and antigen presentation.
- Engineered nanomedicines can sense intratumoral stimuli for targeted immune activation.
- Self-assembled nanomedicines allow co-loading of drugs for synergistic effects and theranostic applications.
Conclusions:
- Nanomedicines offer a versatile platform for improving cancer immunotherapy efficacy and safety.
- Targeted delivery and controlled release by nanomedicines can overcome biological barriers and modulate immune signals.
- Further development of nanomedicines is crucial for advancing personalized cancer treatment in the era of immunotherapy.
Related Concept Videos
01:27Tumor Immunotherapy
1.0K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
1.0K
02:57Targeted Cancer Therapies
8.2K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
8.2K
01:30Cancer Vaccines
742
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
742